Neurocrine Biosciences
NBIX
#1484
Rank
A$21.39 B
Marketcap
A$214.55
Share price
0.10%
Change (1 day)
-1.70%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company